Mural Oncology (MURA) Projected to Post Earnings on Tuesday

Mural Oncology (NASDAQ:MURA) is expected to post its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect Mural Oncology to post earnings of ($1.98) per share for the quarter.

Mural Oncology (NASDAQ:MURA) last released its quarterly earnings data on Tuesday, March 11th. The company reported ($2.01) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.96) by ($0.05). During the same quarter in the prior year, the business earned ($3.57) earnings per share. On average, analysts expect Mural Oncology to post $-8 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Mural Oncology Price Performance

Mural Oncology stock opened at $3.85 on Friday. The business has a 50 day moving average of $3.91 and a 200-day moving average of $3.62. Mural Oncology has a 1 year low of $2.87 and a 1 year high of $5.12. The company has a market capitalization of $66.33 million, a P/E ratio of -0.42 and a beta of 3.66.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $18.00 target price on shares of Mural Oncology in a research report on Wednesday, March 12th.

About Mural Oncology

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.